France First to Act on HHC in Europe

France First to Act on HHC in Europe

France has recently moved to stem the sale of synthetic cannabinoid HHC, an intoxicating hemp-derived product like delta-8 THC.  As of yesterday, June 13, HHC is classified as a drug and all further sales are banned.

The policy shift is guided by research showing that HHC “presents the same risk of abuse and dependence as cannabis,” the French National Agency for the Safety of Medicines and Health Products (ANSM) said.

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

11.21.2024

Domestic US biodiesel blending helps lift October RFS RIN production

Domestic US biodiesel blending helps lift October RFS RIN production

US domestic biodiesel blending of 147.5 million gallons in October produced a monthly high of 221.2 million renewable identification number (RIN) credits for January-October. This was 11.5% above September...

11.21.2024

CWG trades lower as broader animal fats markets hold steady

CWG trades lower as broader animal fats markets hold steady

The US animal fats and oils markets held steady on Thursday November 21, with limited trading as attention shifted toward broader macroeconomic factors and...

11.21.2024

October commercial cattle, hog production above 2023

October commercial cattle, hog production above 2023

US animal protein prices were steady on Thursday November 21. Limited trade was reported from market sources due to the proximity of the extended Thanksgiving holiday weekend in the...

Latest Tweets